NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD
63.11
-1.38 (-2.14%)
The current stock price of ACLS is 63.11 USD. In the past month the price decreased by -11.06%. In the past year, price decreased by -42.44%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ASML | ASML HOLDING NV-NY REG SHS | 36.7 | 290.34B | ||
AMAT | APPLIED MATERIALS INC | 19.3 | 139.77B | ||
LRCX | LAM RESEARCH CORP | 25.6 | 110.42B | ||
KLAC | KLA CORP | 27.54 | 100.24B | ||
TER | TERADYNE INC | 36 | 18.88B | ||
ENTG | ENTEGRIS INC | 34.7 | 15.72B | ||
ENPH | ENPHASE ENERGY INC | 27.36 | 8.59B | ||
ONTO | ONTO INNOVATION INC | 29.81 | 7.88B | ||
NVMI | NOVA LTD | 40.24 | 7.80B | ||
MKSI | MKS INSTRUMENTS INC | 15.67 | 6.94B | ||
AMKR | AMKOR TECHNOLOGY INC | 16.12 | 5.49B | ||
CAMT | CAMTEK LTD | 27.19 | 3.47B |
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. The company is headquartered in Beverly, Massachusetts and currently employs 1,620 full-time employees. The company went IPO on 2000-07-11. The firm offers a complete line of high energy, high current and medium current implanters for all application requirements. In addition to equipment, the Company provides extensive aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Its Purion flagship systems are all based on a common platform, which enables a combination of implant purity, precision and productivity. Combining a single wafer end station, with advanced spot beam architectures (that ensures all points across the wafer see the same beam condition at the same beam angle), Purion products enable process control to optimize device performance and yield, at high productivity. The firm sells its products to semiconductor chip manufacturers around the world.
AXCELIS TECHNOLOGIES INC
108 Cherry Hill Dr
Beverly MASSACHUSETTS 01915 US
CEO: Mary G. Puma
Employees: 1620
Company Website: https://www.axcelis.com/
Investor Relations: https://investor.axcelis.com/
Phone: 19782324001
The current stock price of ACLS is 63.11 USD. The price decreased by -2.14% in the last trading session.
The exchange symbol of AXCELIS TECHNOLOGIES INC is ACLS and it is listed on the Nasdaq exchange.
ACLS stock is listed on the Nasdaq exchange.
14 analysts have analysed ACLS and the average price target is 94.36 USD. This implies a price increase of 49.52% is expected in the next year compared to the current price of 63.11. Check the AXCELIS TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AXCELIS TECHNOLOGIES INC (ACLS) has a market capitalization of 2.04B USD. This makes ACLS a Mid Cap stock.
AXCELIS TECHNOLOGIES INC (ACLS) currently has 1620 employees.
AXCELIS TECHNOLOGIES INC (ACLS) has a resistance level at 63.83. Check the full technical report for a detailed analysis of ACLS support and resistance levels.
The Revenue of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -22.5% in the next year. Check the estimates tab for more information on the ACLS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ACLS does not pay a dividend.
AXCELIS TECHNOLOGIES INC (ACLS) will report earnings on 2025-04-29, after the market close.
The PE ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 10.26. This is based on the reported non-GAAP earnings per share of 6.15 and the current share price of 63.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for ACLS.
The outstanding short interest for AXCELIS TECHNOLOGIES INC (ACLS) is 14.66% of its float. Check the ownership tab for more information on the ACLS short interest.
ChartMill assigns a fundamental rating of 6 / 10 to ACLS. Both the health and profitability get an excellent rating, making ACLS a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months ACLS reported a non-GAAP Earnings per Share(EPS) of 6.15. The EPS decreased by -17.23% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 19.75% | ||
ROA | 14.9% | ||
ROE | 19.85% | ||
Debt/Equity | 0.04 |
ChartMill assigns a Buy % Consensus number of 77% to ACLS. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -61.46% and a revenue growth -22.5% for ACLS